Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers October 31, 2014
Pharmacy Choice - News - Over-the-Counter Drugs - October 31, 2014

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 15 of 15     Go To Page:

10/31/14 - Nielsen Catalina Solutions and Crossix Deliver Breakthrough Television Solution for Pharma
By a News Reporter-Staff News Editor at Entertainment Newsweekly Nielsen Catalina Solutions, a leader in behavior-based TV planning and analytics, and Crossix Solutions, the leader in healthcare marketing analytics, have announced a new collaboration that will enable pharma advertisers and their media agencies to improve how they plan and optimiz
10/30/14 - Aaw Pharmaceuticals Continues Expansion In Kuwait, Launches Three New Pharmacies In October [Global Data Point]
AAW is one of the largest trading and commercial companies in Kuwait and operates in multiple FMCG, pharmaceutical, and retail sectors. AAW Chairman and CEO, Faisal Abdulwahab Ali Al-Mutawa said: "Our investment is to help grow and expand pharmacies in the different communities across Kuwait especially inline with the growing population in Kuwait.
Currency fluctuations had a negative impact of 0.9% for the fiscal nine months of 2014. Worldwide sales for the fiscal nine months of 2013 were positively impacted by an adjustment to previous estimates for Managed Medicaid rebates under the Affordable Care Act, primarily related to new data received from the states in the fiscal first quarter of 2
10/30/14 - YourEncore Launches Center of Excellence to Help Pharma Companies Ensure Patient Safety and Regulatory Compliance [Global Data Point]
"In addition to other challenges, 2014 has been one of the busiest years for pharmaceutical mergers and acquisitions, and this activity has made the monitoring of drug safety especially difficult and chaotic," said Tim Franson, M.D., YourEncore's Chief Medical Officer. The Safety Center of Excellence is composed of industry-best experts in all area
10/29/14 - Sanofi Delivers Business EPS Growth of 10.3% at CER in Q3 2014 [Global Data Point]
Solid sales and business EPS growth at CER in the third quarter&# x0D;. ?Genzyme continued to deliver with sales growth of 24.6%&# x0D;. ?Animal Health grew 12.7% due to strong sales in the U.S. market&# x0D;.
10/28/14 - Axxess Pharma to Sponsor NASCAR Driver Cole Whitt's Race Car in November 9th NASCAR Sprint Cup Series Race
Axxess Pharma Inc., a specialty pharmaceutical and nutritional supplements company is pleased to announce, through its wholly-owned subsidiary, AllStar Health Brands Inc., that it will sponsor NASCAR driver Cole Whitt's race car in the November 9th NASCAR Sprint Cup Series Race. For Axxess Pharma, this is the latest promotional venture the company
10/28/14 - Corbus Pharmaceuticals Commences Trading on OTCQB under Ticker Symbol CRBP
Yuval Cohen, Ph.D., Chief Executive Officer of Corbus Pharmaceuticals, stated, "We are very pleased to have reached this major corporate milestone so quickly and list as a public company. Corbus Pharmaceuticals successfully completed a $10.3 million private placement equity financing in June of 2014 to implement the Company's vision of becoming a..
10/28/14 - Sanofi delivers Business EPS(1) growth of 10.3% at CER in Q3 2014
See Appendix 8 for definitions of financial indicators; Growth in net sales is expressed at constant exchange rates unless otherwise indicated; See page 2. In order to facilitate an understanding of operational performance, Sanofi comments on the business net income statement. In the third quarter of 2014, Sanofi generated sales of ?8,781 milli
10/27/14 - AnthroTronix Receives FDA Clearance for Brain Health Assessment Tool
By a News Reporter-Staff News Editor at Pharma Business Week AnthroTronix, a research and development company that designs health technology, announced it has received U.S. Food and Drug Administration clearance for its computerized cognitive test battery known as DANA?. "We are pleased that DANA? has sought and received FDA clearance, leadi
10/27/14 - Chronic Pain Sufferers Confirm BioElectronics' ActiPatch Therapy Provides Life Changing Pain Relief
BioElectronics Corporation, the maker of advanced drug-free consumer medical devices, today released updated results of its "Try It and Tell Us" 7- day ActiPatch sample program for United Kingdom and Ireland residents who were surveyed about their experience. Visit to view what people in the UK and Ireland are saying ab
10/27/14 - Contract Packaging Resources recalls Assured brand Naproxen Sodium tablets [EMBIN (Emerging Markets Business Information News]
These recalled drugs were distributed nationwide to Dollar Tree and sold via their retail stores. According to FDA, if consumers take the pain reliever' ibuprofen' by mistake, they could suffer serious allergic reactions ranging from mild irritation or hives to serious reactions such as anaphylaxes that may be life-threatening. FDA said that if any
10/27/14 - Eisai and Arena Pharmaceuticals Announce Publication of Pooled Phase 3 Clinical Trial Analysis of BELVIQ lorcaserin HCl CIV in Postgraduate Medicine
By a News Reporter-Staff News Editor at Obesity& Diabetes Week Eisai Inc. and Arena Pharmaceuticals, Inc. announced that a pooled analysis of the BLOOM and BLOSSOM pivotal, Phase 3 clinical trials of BELVIQ was published in the October issue of Postgraduate Medicine, a peer-reviewed medical journal for physicians. In the pooled analysis, BELVIQ 1
10/27/14 - PetLife to Start New Pre-Clinical Study on Escozine for Pets; Results Expected in December
PetLife Pharmaceuticals, Inc., a registered US Veterinary Pharmaceutical company, today announced it has signed an agreement with AllCells to start a pre-clinical study on its major product Escozine for Pets? with the most common canine cancer tumor cell lines. PetLife has engaged Alameda, California- based AllCells, founded in 1998, for its repu
10/26/14 - AnthroTronix Secures FDA Clearance for Brain Health Assessment Tool [Professional Services Close - Up]
"We are pleased that DANA has sought and received FDA clearance, leading the way for this type of game-changing technology," said Corinna Lathan, founder and CEO of AnthroTronix. "With the steady growth of the mHealth movement, technology that has evidence and science-based functionality is critical," said Duke University Medical Center's Murali D
In the U.S., the FDA has accepted for priority review the Biologics License Application for previously treated advanced melanoma and the Prescription Drug User Fee Act goal date for a decision is March 30, 2015. The FDA also granted Opdivo Breakthrough Therapy Designation for this indication. During the third quarter of 2014, the Company and Pfizer
Articles(s): 1 - 15 of 15     Go To Page:

© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


The Diversion of Controlled Substances and the Law
This lesson is supported by:
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement